LianBio American Depositary Shares
LIAN
LIAN was delisted on the 18th of March, 2024.
1 hedge funds and large institutions have $2K invested in LianBio American Depositary Shares in 2025 Q1 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
50% less funds holding
Funds holding: 2 → 1 (-1)
95% less capital invested
Capital invested by funds: $42.1K → $2K (-$40.1K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FIA
FNY Investment Advisers
New York
|
+$68 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RhumbLine Advisers
Boston,
Massachusetts
|
-$39.1K |
LIAN Hedge Fund Activity: Q1 2025 in Review
1 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in LianBio American Depositary Shares (LIAN) for Q1 2025, worth a combined $2K — down 95% from $42.1K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of LIAN and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.
The largest buyer was FNY Investment Advisers, adding an estimated $68. The largest seller was RhumbLine Advisers, exiting entirely with an estimated $39.1K sold.
- 1 institutional investor held LianBio American Depositary Shares (LIAN) as of Q1 2025, down from 2 in Q4 2024.
- Funds reported $2K of LianBio American Depositary Shares stock for Q1 2025, down 95% quarter-over-quarter.
- 0 funds opened new LianBio American Depositary Shares positions in Q1 2025 and 1 closed out, a net change of -1 holder.
- The largest LianBio American Depositary Shares buyer in Q1 2025 was FNY Investment Advisers, an estimated $68 added.
- The largest LianBio American Depositary Shares seller in Q1 2025 was RhumbLine Advisers, an estimated $39.1K sold.
Based on aggregated 13F filings for Q1 2025.